サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1672061

非経口栄養の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）

Global Parenteral Nutrition Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 160 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
非経口栄養の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 160 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の非経口栄養の市場規模は、2024年の81億9,000万米ドルから2033年には146億3,000万米ドルに成長し、2026年～2033年の予測期間中に6.65％の堅調なCAGRを示すと予測されます。

非経口栄養市場は、慢性疾患の有病率の上昇と栄養補給を必要とする患者数の増加を背景に、大きな成長を遂げようとしています。ヘルスケア提供者が患者の予後を改善する上で適切な栄養補給が重要であることを認識するにつれて、非経口栄養ソリューションの需要が高まることが予想されます。この市場には、経口摂取が困難な患者の特定の栄養ニーズを満たすように調整された、アミノ酸、脂質、炭水化物、ビタミンなどのさまざまな製品が含まれます。回復と疾病管理における栄養の役割に対する意識の高まりが、さまざまなヘルスケア環境での非経口栄養の採用を後押ししています。

非経口栄養製剤および送達システムにおける革新もまた、この市場の将来を形成しています。代謝状態や併存疾患など、個々の患者の要件を考慮したカスタマイズ栄養ソリューションの開発は、非経口栄養の有効性を高めています。さらに、スマートポンプや自動化システムなどの注入技術の進歩により、栄養供給の安全性と精度が向上し、非経口栄養に関連する合併症のリスクが低下しています。これらの技術が進化し続けるにつれて、市場は幅広い患者集団に対応する製品の多様化を経験することになると思われます。

さらに、医療機関や製薬会社が栄養補給におけるアンメットニーズを認識していることから、非経口栄養市場は研究開発への投資増加の恩恵を受けると思われます。臨床ガイドラインを推進し、非経口栄養の安全かつ効果的な使用を確保するには、臨床医、栄養士、および業界の利害関係者の協力が不可欠です。規制状況の進展に伴い、規制機関は革新的な製剤の承認プロセスを合理化し、救命栄養療法への迅速なアクセスを促進すると予想されます。非経口栄養を包括的な患者ケア戦略に組み込むことにますます焦点が移り、回復と全体的な健康転帰を高める栄養の重要性が強調されるようになる見通しです。

当社のレポートは、さまざまな業界や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクションです。

市場力学：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに分けています。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場企業を包括的に評価しています。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：実績データと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測しています。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 非経口栄養の産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 非経口栄養の世界市場分析：栄養タイプ別

  • 栄養タイプ別の概要
  • 栄養タイプ別の実績・予測データ分析
  • 炭水化物
  • 非経口脂質エマルジョン
  • 単回投与アミノ酸溶液
  • 微量元素
  • ビタミン・ミネラル

第6章 非経口栄養の世界市場分析：ステージタイプ別

  • ステージタイプ別の概要
  • ステージタイプ別の実績・予測データ分析
  • 成人
  • 小児

第7章 非経口栄養の世界市場分析：適応症別

  • 適応症別の概要
  • 適応症別の実績・予測データ分析
  • アルツハイマー
  • 栄養不足
  • がん治療
  • 糖尿病
  • 慢性腎臓病
  • 希少疾患
  • 嚥下障害
  • 疼痛管理
  • 吸収不良/胃腸障害/下痢
  • その他

第8章 非経口栄養の世界市場分析：販売チャネル別

  • 販売チャネル別の概要
  • 販売チャネル別の実績・予測データ分析
  • オンライン
  • 小売
  • 機関

第9章 非経口栄養の世界市場分析：地域別

  • 地域別の展望
  • イントロダクション
  • 北米の売上分析
    • 概要・実績・予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要・実績・予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要・実績・予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要・実績・予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要・実績・予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第10章 非経口栄養企業の競合情勢

  • 非経口栄養市場の競合
  • 提携・協力・協定
  • 合併・買収
  • 新製品の発売
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Baxter
  • Allergan
  • Otsuka Pharmaceutical Factory Inc.
  • Grifols S.A.
  • Pfizer Inc.（Hospira Inc.）
  • B. Braun Melsungen AG
  • Vifor Pharma
  • Fresenius Kabi AG
  • Sichuan Kelun Pharmaceutical Co. Ltd.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Nutrient Type (USD MN)
  • Carbohydrates Market Sales By Geography (USD MN)
  • Parenteral Lipid Emulsion Market Sales By Geography (USD MN)
  • Single Dose Amino Acid Solution Market Sales By Geography (USD MN)
  • Trace Elements Market Sales By Geography (USD MN)
  • Vitamins & Minerals Market Sales By Geography (USD MN)
  • Analysis By Stage Type (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Pediatrics Market Sales By Geography (USD MN)
  • Analysis By Indication (USD MN)
  • Alzheimers Market Sales By Geography (USD MN)
  • Nutrition Deficiency Market Sales By Geography (USD MN)
  • Cancer Care Market Sales By Geography (USD MN)
  • Diabetes Market Sales By Geography (USD MN)
  • Chronic Kidney Diseases Market Sales By Geography (USD MN)
  • Orphan Diseases Market Sales By Geography (USD MN)
  • Dysphagia Market Sales By Geography (USD MN)
  • Pain Management Market Sales By Geography (USD MN)
  • Malabsorption/GI Disorder/Diarrhea Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Sales Channel (USD MN)
  • Online Market Sales By Geography (USD MN)
  • Retail Market Sales By Geography (USD MN)
  • Institutional Market Sales By Geography (USD MN)
  • Global Parenteral Nutrition Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Parenteral Nutrition Report
  • Market Research Process
  • Market Research Methodology
  • Global Parenteral Nutrition Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Nutrient Type
  • Market Attractiveness Analysis By Stage Type
  • Market Attractiveness Analysis By Indication
  • Market Attractiveness Analysis By Sales Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Nutrient Type (USD MN)
  • Carbohydrates Market Sales By Geography (USD MN)
  • Parenteral Lipid Emulsion Market Sales By Geography (USD MN)
  • Single Dose Amino Acid Solution Market Sales By Geography (USD MN)
  • Trace Elements Market Sales By Geography (USD MN)
  • Vitamins & Minerals Market Sales By Geography (USD MN)
  • Global Market Analysis By Stage Type (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Pediatrics Market Sales By Geography (USD MN)
  • Global Market Analysis By Indication (USD MN)
  • Alzheimers Market Sales By Geography (USD MN)
  • Nutrition Deficiency Market Sales By Geography (USD MN)
  • Cancer Care Market Sales By Geography (USD MN)
  • Diabetes Market Sales By Geography (USD MN)
  • Chronic Kidney Diseases Market Sales By Geography (USD MN)
  • Orphan Diseases Market Sales By Geography (USD MN)
  • Dysphagia Market Sales By Geography (USD MN)
  • Pain Management Market Sales By Geography (USD MN)
  • Malabsorption/GI Disorder/Diarrhea Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Sales Channel (USD MN)
  • Online Market Sales By Geography (USD MN)
  • Retail Market Sales By Geography (USD MN)
  • Institutional Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11213929

Global Parenteral Nutrition Market size is anticipated to grow from USD 8.19 Billion in 2024 to USD 14.63 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 6.65% during the forecast period of 2026 to 2033.

The parenteral nutrition market is set for significant growth, driven by the increasing prevalence of chronic diseases and the rising number of patients requiring nutritional support. As healthcare providers recognize the importance of adequate nutrition in improving patient outcomes, the demand for parenteral nutrition solutions is expected to rise. This market encompasses a range of products, including amino acids, lipids, carbohydrates, and vitamins, tailored to meet the specific nutritional needs of patients unable to consume food orally. The growing awareness of the role of nutrition in recovery and disease management is propelling the adoption of parenteral nutrition across various healthcare settings.

Innovations in parenteral nutrition formulations and delivery systems are also shaping the future of this market. The development of customized nutrition solutions that consider individual patient requirements, such as metabolic conditions and comorbidities, is enhancing the effectiveness of parenteral nutrition. Additionally, advancements in infusion technology, including smart pumps and automated systems, are improving the safety and accuracy of nutrient delivery, reducing the risk of complications associated with parenteral feeding. As these technologies continue to evolve, the market is likely to witness a diversification of product offerings that cater to a wide range of patient populations.

Furthermore, the parenteral nutrition market will benefit from increased investment in research and development, as healthcare organizations and pharmaceutical companies recognize the unmet needs in nutritional support. Collaborative efforts between clinicians, nutritionists, and industry stakeholders will be crucial in advancing clinical guidelines and ensuring the safe and effective use of parenteral nutrition. As the landscape evolves, regulatory bodies are expected to streamline approval processes for innovative formulations, facilitating faster access to life-saving nutritional therapies. The focus will increasingly shift towards integrating parenteral nutrition into comprehensive patient care strategies, emphasizing the importance of nutrition in enhancing recovery and overall health outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Nutrient Type

  • Carbohydrates
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acid Solution
  • Trace Elements
  • Vitamins & Minerals

By Stage Type

  • Adult
  • Pediatrics

By Indication

  • Alzheimer's
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others

By Sales Channel

  • Online
  • Retail
  • Institutional
  • COMPANIES PROFILED
  • Baxter
  • Allergan
  • Otsuka Pharmaceutical Factory Inc.
  • Grifols
  • S.A.
  • B. Braun Melsungen AG
  • Vifor Pharma
  • Fresenius Kabi AG
  • Sichuan Kelun Pharmaceutical Co. Ltd.
  • Pfizer Inc. (Hospira Inc.)
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PARENTERAL NUTRITION INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Nutrient Type
    • 3.7.2 Market Attractiveness Analysis By Stage Type
    • 3.7.3 Market Attractiveness Analysis By Indication
    • 3.7.4 Market Attractiveness Analysis By Sales Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY NUTRIENT TYPE

  • 5.1. Overview By Nutrient Type
  • 5.2. Historical and Forecast Data Analysis By Nutrient Type
  • 5.3. Carbohydrates Historic and Forecast Sales By Regions
  • 5.4. Parenteral Lipid Emulsion Historic and Forecast Sales By Regions
  • 5.5. Single Dose Amino Acid Solution Historic and Forecast Sales By Regions
  • 5.6. Trace Elements Historic and Forecast Sales By Regions
  • 5.7. Vitamins & Minerals Historic and Forecast Sales By Regions

6. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY STAGE TYPE

  • 6.1. Overview By Stage Type
  • 6.2. Historical and Forecast Data Analysis By Stage Type
  • 6.3. Adult Historic and Forecast Sales By Regions
  • 6.4. Pediatrics Historic and Forecast Sales By Regions

7. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY INDICATION

  • 7.1. Overview By Indication
  • 7.2. Historical and Forecast Data Analysis By Indication
  • 7.3. Alzheimers Historic and Forecast Sales By Regions
  • 7.4. Nutrition Deficiency Historic and Forecast Sales By Regions
  • 7.5. Cancer Care Historic and Forecast Sales By Regions
  • 7.6. Diabetes Historic and Forecast Sales By Regions
  • 7.7. Chronic Kidney Diseases Historic and Forecast Sales By Regions
  • 7.8. Orphan Diseases Historic and Forecast Sales By Regions
  • 7.9. Dysphagia Historic and Forecast Sales By Regions
  • 7.10. Pain Management Historic and Forecast Sales By Regions
  • 7.11. Malabsorption/GI Disorder/Diarrhea Historic and Forecast Sales By Regions
  • 7.12. Others Historic and Forecast Sales By Regions

8. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY SALES CHANNEL

  • 8.1. Overview By Sales Channel
  • 8.2. Historical and Forecast Data Analysis By Sales Channel
  • 8.3. Online Historic and Forecast Sales By Regions
  • 8.4. Retail Historic and Forecast Sales By Regions
  • 8.5. Institutional Historic and Forecast Sales By Regions

9. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PARENTERAL NUTRITION COMPANIES

  • 10.1. Parenteral Nutrition Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF PARENTERAL NUTRITION INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Baxter
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Allergan
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Otsuka Pharmaceutical Factory Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Grifols S.A.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Pfizer Inc. (Hospira Inc.)
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. B. Braun Melsungen AG
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Vifor Pharma
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Fresenius Kabi AG
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Sichuan Kelun Pharmaceutical Co. Ltd.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies